Crowdonomics
WatchlistPortfolio
PharmD Live

Reg CF · Preferred Stock · Sep 2020

ClosedReached targetReg CFPreferred Equity
via WeFunderView campaign
Raised
$309.9K / $1.1M max
29% of ceiling · target hit day 302
Investors
182
$1.7K avg
Post-money valuation
$9.4M
pre-money + amount raised

Raised over time

Cumulative raisedInvestors
$308K$154K$0
176880
Sep 1, 2020 · openedAug 31, 2021 · last reading
Target ($250K) hit — Jun 30, 2021, day 302Deadline Apr 30, 2022 — 242 days out

Left axis: cumulative dollars raised. Right axis: cumulative investors. Live figures via WeFunder; investor counts may lag the platform by up to a day.

Financials disclosed in this offering

FY2018–FY2019 · hover for source
$0
FY2018
$0
−$154K
FY2019
RevenueNet income
Metric
FY2018
FY2019 reviewed*
Income statement
Revenue
$0
$0
Cost of goods sold
$0
$0
Net income
$0
-$153,525
Taxes paid
$0
$0
Balance sheet
Cash
$0
$0
Accounts receivable
$0
$0
Total assets
$0
$0
Short-term debt
$0
$147,000
Long-term debt
$0
$0
Total liabilities
$0
$147,000
Other
Headcount
—
15

The fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.

Amendments to this offering

1 amendment
  1. Mar 26, 2021
    Terms not yet extracted from this filing
    Form C/A on EDGAR ↗

Each line compares the amendment with the previous filing of this offering. The quoted reason is the issuer’s own statement from the Form C/A.

Deal terms

Pre-money$9.1M
Post-money$9.4M
Price / share$1.00
Shares offered250,000

Offering details

Target$250,000
Max$1,070,000
Min investment$100
OpenedSep 1, 2020
DeadlineApr 30, 2022
ClosedSep 1, 2021
Days active365

Links & provenance

Campaign pageSEC filing
Source: Manual
0001670254-20-000731

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.